Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia

Documenti analoghi

• Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms
  di: Chiara Elena, et al.
  Pubblicazione: (2011-08-01)
• The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms
  di: Damla Olcaydu, et al.
  Pubblicazione: (2011-03-01)
• Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
  di: Luca Malcovati, et al.
  Pubblicazione: (2014-11-01)
• Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
  di: Francesco Passamonti, et al.
  Pubblicazione: (2008-11-01)
• Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
  di: Yoko Edahiro, et al.
  Pubblicazione: (2024-12-01)